HDII (Hypertension Diagnostics) EV-to-OCF: (As of Aug. 09, 2026)

Hypertension Diagnostics  (OTCPK:HDII) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Hypertension Diagnostics's PE Ratio (TTM) for today is calculated as:

Hypertension Diagnostics's share price for today is $0.0001.
Hypertension Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Hypertension Diagnostics EV-to-OCF Related Terms

The historical data trend for Hypertension Diagnostics's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics EV-to-OCF Chart

Hypertension Diagnostics Annual Data
	Trend	Jun06	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Dec16	Dec17	Dec18
EV-to-OCF		Get a 7-Day Free Trial					-17.49	-1.47	0.00	0.00	-12.11

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
EV-to-OCF	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

HDII vs ESTRF, OCLN, PTOI: EV-to-OCF Comparison

For the Shell Companies subindustry, Hypertension Diagnostics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics EV-to-OCF vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's EV-to-OCF falls into.

Hypertension Diagnostics EV-to-OCF Calculation

Hypertension Diagnostics's EV-to-OCF for today is calculated as:

Hypertension Diagnostics's current Enterprise Value is $0.00 Mil.
Hypertension Diagnostics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Business Description